PubMed Health⌕ Search

Biomedical subjects

Kay Elder

Publications and source records attributed to Kay Elder.

4 recordsLinked to original sources

Base editing reveals an essential role for NANOG in human embryogenesis.

Understanding how the first cell lineages in human development are specified and maintained has fundamental importance and clinical implications for regenerative medicine, infertility and pregnancy loss. Although mouse models have provided valuable insights into transcription factors regulating early development, translating these findings to human embryos has been limited by ethical, technical and biological constraints. Functional studies of transcription factors in human embryos have been hindered by nuclease-based genome editing approaches that induce genotoxicity1-3. Here, to overcome this, we applied ABE8e adenine base editing4,5 to precisely target an exon splice donor site, resulting in a splicing defect and functional knockout of the developmental regulator NANOG in human embryos. This approach did not trigger genotoxicity and showed limited off-target editing. Loss of NANOG disrupts pluripotent epiblast specification and instead cells differentiate towards a primitive endoderm (yolk sac) or trophectoderm (placental) transcriptional programme. Retention of primitive endoderm differentiation in NANOG-edited human embryos reveals a functional compensation that is distinct from mouse, underscoring the importance of directly investigating human development. Our findings demonstrate an essential role for NANOG in human pluripotency and epiblast specification and highlight the utility of base editing for functional interrogation of human development.

Journal Article↗

Soluble HLA-G release by the human embryo: an interesting artefact?

Several publications have recently claimed that early human embryos release soluble human leukocyte antigen-G (HLA-G), and that there is a direct positive relationship between the quantity of this protein secreted and embryo quality and viability. These publications report a detection limit of 1 or 10 ng/ml of medium, and the quantity of material released was of the order of magnitude from 3 to 80 ng per day and per embryo. The protein content of a human preimplantation embryo can be estimated at 45-50 ng. This means that the HLA-G release reported could be from 10 to 100% and above the total protein content of the embryo. In recent decades, bio-industry has intensively engineered Chinese hamster ovary cells and optimized their gene expression in order to achieve extremely high yields of recombinant protein secretions reaching 50 pg per cell and per day. This is 100 times lower than what is proposed for soluble HLA-G release by the embryo. It is obvious that the embryo releases signals, but these are unlikely to be secreted at the order of magnitude of the concentrations that have been so far estimated.

Animals↗

Cytoplasmic transfer in oocytes: biochemical aspects.

Cytoplasmic control of preimplantation development is not a 'new' concept; the first cytoplasmic transfer experiment was performed in the mouse during the early 1980s, as a means of overcoming cleavage arrest at the 2-cell stage, the '2-cell block'. Since the first human pregnancy following the transfer of cytoplasm from donor oocytes into the oocytes of a patient with a history of poor embryo development and recurrent implantation failure in 1997, >30 children have been born after direct injection of ooplasm from fresh, mature or immature, or cryopreserved-thawed donor oocytes into recipient oocytes via a modified ICSI technique. Transfer of ooplasm was thus applied with astonishing speed in humans, in the absence of extensive research to evaluate the efficacy and the possible risks of the method. This review focuses on biochemical mechanisms by which transfer of ooplasm might confer a benefit: by correcting a putative imbalance between anti- and pro-apoptotic factors and/or correction of defective mitochondrial membrane potential. We also emphasize the 'empirical' state of this technique, and the related risks.

Animals↗